Skip to content
OpenAI News

Introducing GPT-Rosalind for life sciences research

OpenAI released GPT-Rosalind on April 16, 2026, and made it available as a research preview in ChatGPT, Codex, and the API for qualified customers. The post says it targets biology, drug discovery, and translational medicine, and adds a free Codex life sciences plugin connecting to 50+ scientific tools and data sources. The real signal is deployment breadth: Amgen, Moderna, and Thermo Fisher Scientific are involved, but the post does not disclose model size, pricing, or benchmark scores.

Why it matters: OpenAI released GPT-Rosalind, a reasoning model for biology, drug discovery and translational medicine, as a research preview in ChatGPT, Codex and the API for vetted customers.

Read the original ↗Export Markdown